MenucLOSE
  • Aureka Prism
  • OpenDDE
  • Technology
  • Pipeline
  • aBOUT
  • News
  • Careers
Contact us
The latest from Aureka
NEWSPublications
News

tag
  • All
  • Scientific Publication
  • Interview
  • CEO Insights
  • Biotech Conference
  • Health Tech Awards
  • Aureka Tech
  • Microfluidic
  • Aureka News
  • AI
  • Synthetic Biology
No data
  • { 2026/08/27 /}

    Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
    Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result

    #Aureka News#Scientific Publication

  • { 2026/08/10 /}

    Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
    Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery

    #Aureka News

  • { 2026/07/06 /}

    Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery
    Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery

    #Aureka News#Aureka Tech

  • { 2026/04/09 /}

    Aureka participates in ChAbS Annual Conference 2026
    Aureka participates in ChAbS Annual Conference 2026

    #Biotech Conference

  • { 2025/12/04 /}

    Aureka Biotechnologies Featured in Biocom California Member Spotlight
    Aureka Biotechnologies Featured in Biocom California Member Spotlight

    #Aureka News

  • { 2025/11/10 /}

    Aureka participates in PEGS EUROPE
    Aureka participates in PEGS EUROPE

    #Biotech Conference

SHow more
Publications


Building a Scalable
TECHBIO Company,
Empowered by a Data-driven AI Platform

site navigation

Aureka Prism

OpenDDE

Technology

Pipeline

About

News

Careers

CONTACT
contact@aurekabio.com
  • 
  • 

{ © 2026 CopyRight Aureka /}

